Back to Browse Journals » HIV/AIDS - Research and Palliative Care » Volume 3

Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience

Authors Lake JE, Friedman RK, Cunha CB, Cardoso SW, Veloso VG, Currier JS, Grinsztejn B

Published Date July 2011 Volume 2011:3 Pages 61—68

DOI http://dx.doi.org/10.2147/HIV.S18667

Published 1 July 2011

Jordan E Lake1, Ruth K Friedman2, Cynthia B Cunha2, Sandra W Cardoso2, Valdilea G Veloso2, Judith S Currier1, Beatriz Grinsztejn2
1Division of Infectious Diseases, University of California at Los Angeles, Los Angeles, CA, USA; 2Fundação Oswaldo Cruz – Instituto de Pesquisa Clínica Evandro Chagas/IPEC, Rio de Janeiro, State of Rio de Janeiro, Brazil

Background: Fifty percent of people living with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) worldwide are female. In Brazil, for example, 240,000 women are infected with HIV, rates of infection in women have increased over the last two decades, and addressing HIV prevention and treatment for women at risk for, or living with, HIV/AIDS remains a challenge. To better address the needs of women living with HIV in Brazil, the Instituto de Pesquisa Clínica Evandro Chagas – Fundação Oswaldo Cruz (IPEC-FIOCRUZ) HIV Women’s Cohort was established in 1996 to study the natural history of women seeking HIV care. This analysis describes the characteristics of women in the cohort who participated in HIV clinical trials between 1999 and 2008.
Methods: A total of 736 Women’s Cohort participants were in active follow-up and 665 participants from the Women’s Cohort were included in univariable and multivariable analyses to determine socioeconomic and sociodemographic factors associated with women’s participation in HIV clinical trials at our site.
Results: Of the complete cohort, 23% participated in a clinical trial between January 1999 and July 2008. Odds of participation decreased for women who were younger than 35 years old, currently employed, had an HIV-positive sexual partner, and/or who reported a lifetime history of illicit drug use. Alternatively, the odds of participation increased for women who had more than 8 years of formal education, were living independently, and/or were married or cohabitating.
Conclusion: The rate of participation in HIV clinical trials by women in the IPEC-Fiocruz Cohort was similar to other published cohorts, but identification of local risk factors and barriers to participation remains important. Our analysis offers a novel description of the factors associated with participation in HIV clinical trials among women in care at IPEC-FIOCRUZ in Rio de Janeiro, Brazil.

Keywords: AIDS, Brazil, South America, clinical trial participation
 

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Osteopenia and osteoporosis in people living with HIV: multiprofessional approach

Lima AL, Oliveira PR, Plapler PG, Marcolino FM, Meirelles ES, Sugawara A, Gobbi RG, Godoy-Santos AL, Camanho GL

HIV/AIDS - Research and Palliative Care 2011, 3:117-124

Published Date: 8 December 2011

A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers

Levine AJ, Palomo M, Hinkin CH, Valdes-Sueiras M, Lopez E, Mathisen G, Donovan S, Singer EJ

Neurobehavioral HIV Medicine 2011, 3:79-86

Published Date: 26 September 2011

Iatrogenic disease in the elderly: risk factors, consequences, and prevention

Sompol Permpongkosol

Clinical Interventions in Aging 2011, 6:77-82

Published Date: 21 March 2011

The impact of asthma on the gastrointestinal tract (GIT)

Warren Antonio Vieira, Etheresia Pretorius

Journal of Asthma and Allergy 2010, 3:123-130

Published Date: 9 September 2010

Effect of biologic agents on radiographic progression of rheumatoid arthritis

Gabriel J Tobón, Alain Saraux, Valérie Devauchelle-Pensec

Reports in Medical Imaging 2010, 3:35-44

Published Date: 31 August 2010

Adherence to antiretroviral therapy in Nigeria: an overview of research studies and implications for policy and practice

Emmanuel Monjok, Andrea Smesny, Ita B Okokon, et al

HIV/AIDS - Research and Palliative Care 2010, 2:69-76

Published Date: 30 March 2010

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009